Genetic polymorphisms of the renin-angiotensin system and angiographic extent and severity of coronary artery disease: The CORGENE study

Human Genetics

Volumn 99, Issue 1, 1996, Pages 66-73

  Jeunemaitre, Xavier ^a   Ledru, François ^a   Battaglia, Salvatore ^a   Guillanneuf, Marie Thérèse ^a   Courbon, Dominique ^a   Dumont, Cécile ^a   Darmon, Olivier ^a   Guize, Louis ^a   Guermonprez, Jean Léon ^a   Diebold, Benoît ^a   Ducimetière, Pierre ^a  

^a HÔPITAL BROUSSAIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY DISEASE; DISEASE SEVERITY; FEMALE; GENE DELETION; GENE INSERTION; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0031060669     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004390050313     Document Type: Article

References (48)

1. Adamski SW, Grega GJ (1988) Contribution of kininase II to the warning of vascular actions of bradykinin. Am J Physiol 254:1042-1050
2. Alderman MH, Madhavan S, Ooi WL, Cohen H, Sealey JE, Laragh JH (1991) Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med 324:1098
3. Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LSC, McGoon DL, Murphy ML, Rose BB (1975) AHA committee report: a reporting system on patients evaluated for coronary artery disease. Report of the ad hoc committee for grading of coronary artery disease. Council of Cardiovascular Surgery, American Heart Association. Circulation 51:5-40
4. Benetos A, Topouchian J, Ricard S, Gautier S, Bonnardeaux A, Asmar R, Poirier O, Soubrier F, Safar M, Cambien F (1995) Influence of angiotensin II type I receptor polymorphism on aortic stiffness in never-treated hypertensive patients. Hypertension 26:44-47
5. Beohar N, Damaraju S, Prather A, Yu QT, Raizner A, Kleiman NS, Roberts R, Marian AJ (1995) Angiotensin-I converting enzyme genotype DD is a risk factor for coronary artery disease. J Invest Med 43:275-280
6. Berck BC, Wekshtein V, Gordon HM, Tsuda T (1989) Angiotensin II stimulated protein synthesis in cultured vascular smooth cells. Hypertension 13:305-312
7. Bohn M, Berge KE, Bakken A, Erikssen J, Berg K (1993) Insertion/deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme and myocardial infarction. Clin Genet 44:292-297
8. Bonithon-Kopp C, Ducimetiere P, Touboul PJ, Feve JM, Billard E, Courbon D, Heraud V (1994) Plasma angiotensin-converting enzyme activity and carotid wall thickening. Circulation 89:952-954
9. Bonnardeaux A, Davies E, Jeunemaitre X, Fery I, Charru A, Clauser E, Tiret L, Cambien F, Corvol P, Soubrier F (1994) Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 24:63-69
10. Cambien F, Poirier O, Lecerf L, Evans A, Cambou J-P, Arveiler D, Luc G, Bard J-M, Bara L, Ricard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F (1992) Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359:641-644
11. Cambien F, Costerousse O, Tiret L, Poirier O, Lecerf L, Gonzales F, Evans A, Arveiler D, Cambou JP, Luc G, Rakotavao R, Ducimetiere P, Soubrier F, Alhenc-Gelas F (1994) Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation 90:669-676
12. CASS principal investigators (1981) The National Heart, Lung, Blood Institute Coronary Artery Surgery Study. Circulation 63:II-1-II-81
13. Costerousse O, Alegrini J, Lopez M, Alhenc-Gelas F (1993) Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J 290:33-40
14. Friedl W, Krempler F, Paulweber B, Fichier M, Sandhofer F (1995) A deletion polymorphism in the angiotensin converting enzyme is not associated with coronary heart disease in an Austrian population. Atherosclerosis 112:137-143
15. Gardemann A, Weiß T, Schwartz O, Eberbach A, Katz N, Herhrlein FW, Tillmanns H, Waas W, Haberbosch W (1995) Gene polymorphism but not catalytic activity of angiotensin I-converting enzyme is associated with coronary artery disease and myocardial infarction in low-risk patients. Circulation 92:2796-2799
16. Hamsten A, Walldius G, Szamosi A, Dahlen G, de Faire U (1986) Relationship of angiographically defined coronary artery disease to serum lipoproteins and apolipoproteins in young survivors of myocardial infarction. Circulation 73:1097-1110
17. Hopkins PN, Williams RR, Kuida H, Stults BM, Hunt SC, Barlow GK, Ash O (1988) Family history as independent risk factor for incident coronary artery disease in a high-risk cohort in Utah. Am J Cardiol 62:703-707
18. Ishigami T, Umemura S, Iwamoto T, Tamura K, Hibi K, Yamaguchi S, Nyuui N, Kimura K, Miyazaki N, Ishii M (1995) Molecular variant of angiotensinogen gene is associated with coronary atherosclerosis. Circulation 91:951-954
19. Jeunemaitre X, Soubrier F, Kotelevtsev Y, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel J-M, Corvol P (1992) Molecular basis of human hypertension. Role of angiotensinogen. Cell 71:169-178
20. Kamitani A, Raguki H, Higaki J, Ohishi M, Shi SJ, Takami S, Nakata Y, Higashino Y, Fujii K, Mikami H, Miki T, Ogihara T (1995) Enhanced predictability of myocardial infarction in Japanese by combined genotype analysis. Hypertension 25:950-953
21. Katsuya T, Koike G, Yee TW, Sharpe N, Jackson R, Norton R, Horiuchi M, Pratt RE, Dzau VJ, MacMahon S (1995) Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet 345:1600-1603
22. Lachurié ML, Azizi M, Guyene TT, Alhenc-Gelas F, Ménard J (1995) Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects. Circulation 91:2933-2942
23. Lindpaintner K, Pfeffer M, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, Buring J, Hennekens CH (1995) A prospective evaluation of an angiotensin-converting enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 332:706-711
24. Ludwig EH, Corneli PS, Anderson JL, Marshall HW, Lalouel JM, Ward RH (1995) An angiotensin-converting enzyme polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation 91:2120-2124
25. Mancini JG, Simon S, McGuillem MJ, Le Free MT, Friedman HZ, Vogel RA (1987) Automated quantitative coronary arteriography: morphologic and physiologic validation in vivo of a rapid digital angiographic method. Circulation 75:452-460
26. Marre M, Bernardet P, Gallois Y, Savagner F, Guyene TT, Hallab M, Cambien F, Passa P, Alhenc-Gelas F (1994) Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels and diabetic retinal and renal complications. Diabetes 43: 384-388
27. Maseri A, L'Abbate A, Baroldi G, et al (1978) Coronary vasospasm as a possible cause of myocardial infarction: a conclusion derived from the study of "preinfarction angina". N Engl J Med 299:1271-1277
28. Miettinen HE, Korperla K, Hämäläinen L, Kontula K (1994) Polymorphisms of the apolipoprotein and angiotensin converting enzyme genes in young North Karelian patients with coronary heart disease. Hum Genet 94:189-192
29. Miller NE, Hammet F, Saltissi S, Rao S, Zeller H Van, Coltart J, Lewis B (1981) Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins. BMJ 282:1741-1744
30. Nakai K, Itoh C, Miura Y, Hotta K, Musha T, Itoh T, Miyakawa T, Iwasaki R, Hiramori K (1994) Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation 90:2199-2202
31. Oike Y, Hata A, Ogata Y, Numata Y, Shido K, Kondo K (1995) Angiotensin converting enzyme as a genetic risk factor for coronary artery spasm. J Clin Invest 96:2975-2979
32. Pfeffer MA, Braunwald E, Moyé LA, et al on behalf of the SAVE investigators (1992) Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. N Engl J Med 327:669-677
33. Powell JS, Clozel JP, Müller RKM, Kuhn H, Hefti F, Hosang M, Baumgartner HR (1989) Inhibitors of angiotensin converting enzyme prevent myointimal proliferation after vascular injury. Science 245:186
34. Raguki H, Kim DK, Krieger JE, Wang DS, Dzau VJ, Pratt RE (1994) Induction of angiotensin converting enzyme in the neointima after vascular injury. Possible role in restenosis. J Clin Invest 93:339-346
35. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F (1990) An insertion/deletion polymorphism in the angiotensin I-converting enzyme accounting for half of the variance of serum enzyme levels. J Clin Invest 86:1343
36. Rigat B, Hubert C, Corvol P, Soubrier F (1992) The ACE/ID polymorphism detected by PCR amplification. Nucleic Acids Res 20:1433
37. Ross J, Brandenburg RO, Dinsmore RE, Friesinger GC, Hultgren HH, Repine CJ, Rapaport E, Ryan TJN, Weinberg SL, Williams JF (1987) Guidelines for coronary angiography: a report of the American College of Cardiology/American Heart Association Task Force on assessment of diagnostic and therapeutic cardiovascular procedure. Circulation 76:4
38. Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801-809
39. Schunkert H, Hense HW, Holmer SR, Stender M, Perz S, Keil U, Lorell BH, Riegger GAJ (1994) Association between a deletion polymorphism of the angiotensin-converting enzyme gene and left ventricular hypertrophy. N Engl J Med 330:1634-1638
40. Schuster H, Wienker TF, Stremmler U, Noll B, Steinmetz A, Luft FC (1995) An angiotensin-converting enzyme gene variant is associated with acute myocardial infarction in women but not in men. Am J Cardiol 76:601-603
41. Sing CF, Moll PP (1990) Genetics of atherosclerosis. Annu Rev Genet 24:171-187
42. Sullivan DR, Thomas HM, Freedman S (1990) A new method of scoring coronary angiograms to reflect extent of coronary atherosclerosis and improve correlation with major risk factors. Am Heart J 119:1262-1267
43. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F (1992) Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 51:197-205
44. Tiret L, Bonnardeaux A, Poirier O, Ricard S, Marques-Vidal P, Evans A, Arveiler D, Luc G, Kee F, Ducimetiere P, Cambien F (1994) Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet 344:910-913
45. Tiret L, Ricard S, Poirier O, Arveiler D, Cambou JP, Luc G, Evans A, Nicaud V, Cambien F (1995) Genetic variation at the angiotensinogen locus in relation to high blood pressure and myocardial infarction: the ECTIM study. J Hypertens 13:311-317
46. Ueda S, Elliott HL, Morton JJ, Connell JMC (1995) Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for angiotensin-converting enzyme. Hypertension 25:1266-1269
47. Wal AC Van der, Becker AE, Loos CM Van der, Das P (1994) Site of intimai rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 89:36-44
48. Winkelmann BR, Nauck M, Klein B, Russ AP, Böhm BO, Siekmeier R, Ihnken K, Verho M, Groß W, März W (1996) Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with increased plasma angiotensin-converting enzyme activity but not with increased risk for myocardial infaraction and coronary artery disease. Ann Intern Med 125:19-25